SkinHealth Systems (SKIN) Invested Capital (2020 - 2026)

SkinHealth Systems (SKIN) has 7 years of Invested Capital data on file, last reported at $158.2 million in Q1 2026.

• Invested Capital for Q1 2026 came in at $158.2 million, up 243.42% year-over-year; the trailing twelve-month figure through Mar 2026 was $158.2 million (up 243.42% YoY), and the FY2025 annual result was $185.0 million, up 257.15% from the prior year.
• Invested Capital fell to $158.2 million in Q1 2026 per SKIN's latest filing, from $185.0 million in the prior quarter.
• Over five years, Invested Capital peaked at $345.4 million in Q2 2022 and troughed at $46.1 million in Q1 2025.
• A 5-year average of $137.4 million and a median of $90.0 million in 2023 frame the typical range for Invested Capital.
• The sharpest annual moves came in 2022 and 2023: Invested Capital soared 2049.38% in 2022, then tumbled 64.45% in 2023.
• A 5-year view of Invested Capital shows it stood at $167.1 million in 2022, then plunged by 64.45% to $59.4 million in 2023, then declined by 12.77% to $51.8 million in 2024, then soared by 257.15% to $185.0 million in 2025, then dropped by 14.5% to $158.2 million in 2026.
• Business Quant data shows SKIN's Invested Capital at $158.2 million in Q1 2026, $185.0 million in Q4 2025, and $65.7 million in Q3 2025.